What are you looking for?

Library
Poster
Full Title

Quantification Of The Effect Of Smoking And Smoking Cessation On Lipid Parameters: A Meta-Analysis


Authored by  A van der Plas, G de La Bourdonnaye, G Baker, R Weitkunat, F Lüdicke

Presented at ACE 2013     

Abstract

Purpose: To quantify the effect of smoking and smoking cessation on lipid levels. Methods: PubMed was searched to identify publications which reported lipid levels in smokers and non-smokers, as well as articles reporting the effect of smoking cessation on these lipid parameters. A fixed effect model was used to perform the meta-analyses in Revman version 5 if there were at least 3 studies evaluating the same parameter. Results: 17 studies reporting smoking cessation were identified and 70 studies evaluating smoking and lipid parameters levels. We found that smokers had decreased levels of HDL and APO AI

quantification-of-the-effect-of-smoking-and-smoking-cessation-on-lipid-parameters-a-meta-analysis

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products (“RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.